Erkki Ruoslahti - 09 Jan 2023 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Reporting relationship: Director
Issuer ticker: LSTA
Reported as of: 09 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Jan 2023, 15:20:29 UTC
Prior SEC filing: 16 Sep 2022
Source filing: View source filing
Reporting owner signature: James Nisco, Attorney-in-fact for Erkki Ruoslahti

Key filing fact

Erkki Ruoslahti filed Form 4 for LISATA THERAPEUTICS, INC. (LSTA) on 11 Jan 2023.

Key facts

This page summarizes Erkki Ruoslahti's Form 4 filing for LISATA THERAPEUTICS, INC. (LSTA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Jan 2023, 15:20.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

Shares, units, or other non-derivative securities reported in this filing.

LSTA transaction

Award

LSTA holding

No transaction description listed

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 2 footnotes

Footnote F1

Represents 20,000 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2024.

Footnote F2

Includes 20,000 unvested restricted stock units.